Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability
AK Kushwaha, PR Vuddanda… - BioMed research …, 2013 - Wiley Online Library
Raloxifene hydrochloride (RL‐HCL) is an orally selective estrogen receptor modulator
(SERM) with poor bioavailability of nearly 2% due to its poor aqueous solubility and …
(SERM) with poor bioavailability of nearly 2% due to its poor aqueous solubility and …
Engineered Porous Beta-Cyclodextrin-Loaded Raloxifene Framework with Potential Anticancer Activity: Physicochemical Characterization, Drug Release, and …
JK Alwattar, MM Mehanna - International Journal of Nanomedicine, 2024 - Taylor & Francis
Background Cancer ranks as the second most common cause of mortality as depicted by the
World Health Organization, with one in six deaths being cancer-related mortality. Taking the …
World Health Organization, with one in six deaths being cancer-related mortality. Taking the …
[图书][B] Biopolimer kitosan dan penggunaannya dalam formulasi obat
Page 1 PENERBIT GRANITI Anggota IKAPI (181/JTI/2017) Telp. 081357827429/081357827430
Email: penerbitgraniti@gmail.com Penyusunan buku ini dilandasi oleh perkembangan ilmu …
Email: penerbitgraniti@gmail.com Penyusunan buku ini dilandasi oleh perkembangan ilmu …
Formulation and evaluation of immediate release tablet using response surface methodology
SC Atram - Asian Journal of Pharmaceutics (AJP), 2011 - asiapharmaceutics.info
The purpose of the present work was to develop an optimized immediate release tablet for
hypertensive patients using amlodipine besylate as a model drug candidate by optimization …
hypertensive patients using amlodipine besylate as a model drug candidate by optimization …
[PDF][PDF] Formulation and evaluation of clarithromycin immediate release film coated tablets
M Rajesh, K Nagaraju, SHSM Buhary - cellulose, 2012 - scholar.archive.org
The main goal of this study was to develop a stable formulation of antibiotic drug
clarithromycin as an immediate-release tablet. The task of developing immediate release …
clarithromycin as an immediate-release tablet. The task of developing immediate release …
[PDF][PDF] Advanced PEGylation for the development of raloxifene hydrochloride, BCS class II drug
JJ Bandela, CH Anupama - Journal of Young Pharmacists, 2009 - jyoungpharm.org
The aim of this study is to enhance the dissolution rate of raloxifene hydrochloride and to
prepare tablets by PEGylation. The high-molecular-weight polyethylene glycols, PEG 15 000 …
prepare tablets by PEGylation. The high-molecular-weight polyethylene glycols, PEG 15 000 …
[PDF][PDF] A Study on the Effect of disintegrants and Processing Methods on the Physicochemical and In Vitro Release Characteristics of Immediate Release Tablets of …
D Akiladevi, M Nappinnai, T Sudha - Asian J. Res. Pharm. Sci, 2017 - researchgate.net
The present investigation attempted to study the effect of disintegrants and processing
methods on the physicochemical and in vitro release characteristics of immediate release …
methods on the physicochemical and in vitro release characteristics of immediate release …
[PDF][PDF] Development and evaluation of immediate release tablets of dasatinib using sodium starch glycolate as super disintegrants
CK Sahoo, M Sudhakar, S Bhanja… - … International Journal of …, 2017 - academia.edu
The present study was undertaken to develop immediate release (IR) tablets of Dasatinib a
selective tyrokinase inhibitor (TKI) which is used in treatment of chronic myeloid leukaemia …
selective tyrokinase inhibitor (TKI) which is used in treatment of chronic myeloid leukaemia …
[PDF][PDF] Formulation and evaluation of Raloxifene hydrochloride tablets with improved dissolution profile
N Smita, S Sanidhya, V Bhaskar - Int. J. Adv. Pharm, 2016 - core.ac.uk
The objective of this research activity was to formulate and evaluate Raloxifene
Hydrochloride (RLX HCl) tablets (BCS class II drug) with enhanced aqueous solubility …
Hydrochloride (RLX HCl) tablets (BCS class II drug) with enhanced aqueous solubility …